


Healthcare News Roundup: HIV/AIDS
HSMN NewsFeed - 7 Nov 2007
Monogram Obtains Coverage for Trofile(TM) Assay from California ADAP Program
Monogram Obtains Coverage for Trofile(TM) Assay from California ADAP Program
HSMN NewsFeed - 15 Oct 2007
UPDATE: FDA Approves ISENTRESS(TM) (raltegravir) Tablets, First-in-Class Oral HIV-1 Integrase Inhibitor
UPDATE: FDA Approves ISENTRESS(TM) (raltegravir) Tablets, First-in-Class Oral HIV-1 Integrase Inhibitor
HSMN NewsFeed - 3 Oct 2007
Bioject Announces Roche and Trimeris Update on the Use of Fuzeon(R) with Biojector(R) 2000
Bioject Announces Roche and Trimeris Update on the Use of Fuzeon(R) with Biojector(R) 2000
HSMN NewsFeed - 1 Oct 2007
Theratechnologies Reports Positive 52-Week Phase 3 Results for its Lead Drug Candidate Tesamorelin
Theratechnologies Reports Positive 52-Week Phase 3 Results for its Lead Drug Candidate Tesamorelin
HSMN NewsFeed - 20 Sep 2007
FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
HSMN NewsFeed - 18 Sep 2007
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug Selzentry(TM) (Maraviroc)
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug Selzentry(TM) (Maraviroc)
